StonvexLoading…
StonvexStonvexStonvexCore line items from NVRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $549.80M | $2.24B | $1.69B | $1.11B |
Operating Income | $793.00K | $4.25M | $39.94M | $23.46M |
Net Income | $-10.66M | $-167.60M | $-83.32M | $-61.00M |
EPS (Diluted) | $-0.13 | $-2.08 | $-1.03 | $-0.76 |
Total Assets | $2.70B | $2.71B | $2.79B | $2.77B |
Total Liabilities | $2.43B | $2.41B | $2.39B | $2.35B |
Cash & Equivalents | $105.70M | $103.67M | $115.36M | $97.80M |
Free Cash Flow OCF − CapEx | $-12.19M | $-39.87M | $-29.41M | $-32.09M |
Shares Outstanding | 82.29M | 81.45M | 80.54M | 80.48M |